Alexia Rouland

European Association for the Study of the Liver (<scp>EASL</scp>), European Association for the Study of Diabetes (<scp>EASD</scp>) and European Association for the Study of Obesity (<scp>EASO</scp>) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes

Anne-Laure Sberna, Benjamin Bouillet, Alexia Rouland et al. · Diabetic Medicine · 2017 · 311 citations

Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus

Bruno Vergès, Laurence Duvillard, Jean-Paul Paı̈s de Barros et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2018 · 65 citations · Full text

Hyperlipidemia, Insulin Signaling, Oxidative Stress +19

Liraglutide Increases the Catabolism of Apolipoprotein B100–Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression

Bruno Vergès, Laurence Duvillard, Jean-Paul Paı̈s de Barros et al. · Diabetes Care · 2021 · 50 citations · Full text

Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes

Damien Denimal, Victoria Bergas, Jean‐Paul Pais‐de‐Barros et al. · Cardiovascular Diabetology · 2023 · 34 citations · Full text

Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins

Bruno Vergès, Jonathan Hassid, Alexia Rouland et al. · Diabetes & Metabolism · 2021 · 25 citations